DBCO- (PEG) 3-VC-PAB-MMAE
This product features the cytotoxic payload MMAE conjugated via a DBCO-PEG3-vc-PAB cleavable linker. It is designed for constructing antibody-drug conjugates (ADCs) for targeted cancer therapy research. The linker enables controlled drug release, facilitating the study of ADC efficacy and mechanism in both in vitro and in vivo models.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Smiles
CC[C@H] (C) [C@@H] ([C@@H] (CC (N1[C@@H] (CCC1) [C@@H] ([C@@H] (C) C (N[C@H] (C) [C@@H] (O) C2=CC=CC=C2) =O) OC) =O) OC) N (C ([C@H] (C (C) C) NC ([C@H] (C (C) C) N (C (OCC3=CC=C (NC ([C@H] (CCCNC (N) =O) NC ([C@H] (C (C) C) NC (CCOCCOCCOCCNC (CCC (N (C4) C5=C (C=CC=C5) C#CC6=C4C=CC=C6) =O) =O) =O) =O) =O) C=C3) =O) C) =O) =O) C
Molecular Formula
C86H124N12O18
Molecular Weight
1613.97
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
